LIB Therapeutics is a privately held, late-stage biopharmaceutical company dedicated to bringing novel, safe and convenient subcutaneous and oral PCSK9 inhibitors to the millions of patients at very high and high-risk of cardiovascular disease (CVD), and the 30 million with familial hypercholesterolemia (FH), who require additional large reductions in low density lipoprotein-cholesterol (LDL-C) despite maximally tolerated statins and other lipid lowering agents.
| Website | https://www.libtherapeutics.com/ |
| Employees | 9 (3 on RocketReach) |
| Founded | 2015 |
| Address | 5375 Medpace Way, Cincinnati, Ohio 45227-1543, US |
| Industry | Biotechnology Research |
| Keywords | Therapeutics Research, Cardiovascular Disease, Pharmaceutical Research, Biopharmaceutical, Novel Therapeutics, Heart Disease Treatment, Atherosclerosis Treatment, Drug Development, Clinical Research, Patient Care, Health Solutions |
| Competitors | Amgen, Genentech, Bristol Myers Squibb, Pfizer, Roche, AstraZeneca, Merck & Co., Inc., GSK, Lilly India, Novartis +44 more (view full list) |
Looking for a particular LIB Therapeutics employee's phone or email?
LIB Therapeutics Questions
Evan Stein is the CEO of LIB Therapeutics.
3 people are employed at LIB Therapeutics.
LIB Therapeutics is based in Cincinnati, Ohio.
Top LIB Therapeutics Employees
-
Evan Stein
Chief Executive Officer at LIB Therapeutics
Hollywood, FL, US21 -
24
-
Kristen Miller
Vice President, Brand Communications at LIB Therapeutics
Philadelphia, PA, US25+
